| Mrs Christine R Peterson, FNP | |
|
802 2nd St Nw, Bowman, ND 58623-4483 | |
| (701) 523-5555 | |
| (701) 523-7107 |
| Full Name | Mrs Christine R Peterson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 26 Years |
| Location | 802 2nd St Nw, Bowman, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750385399 | NPI | - | NPPES |
| 19699 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R24643 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southwest Healthcare Services | Bowman, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Healthcare Services | 3173512704 | 7 |
News Archive
Revolutions Medical Corporation, producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, announced today that recent mass media reports that CT scans cause cancer could rapidly elevate MRI as the technology of choice for musculoskeletal scans and more.
At the third plenum held earlier this month, the Chinese government announced reforms to further drive urbanisation in China. After already experiencing the largest human migration in history, what are the public health consequences of this mass movement from rural towns to cities?
Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today announced it plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration by the end of 2014 for the approval of eteplirsen for the treatment of Duchenne muscular dystrophy (DMD).
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular disease, today announced that it received notification from the NASDAQ Stock Market that the Company has demonstrated compliance with the minimum stockholders' equity requirement for the NASDAQ Global Market
› Verified 6 days ago
| Entity Name | Southwest Healthcare Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023083714 PECOS PAC ID: 3173512704 Enrollment ID: O20041005000745 |
News Archive
Revolutions Medical Corporation, producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, announced today that recent mass media reports that CT scans cause cancer could rapidly elevate MRI as the technology of choice for musculoskeletal scans and more.
At the third plenum held earlier this month, the Chinese government announced reforms to further drive urbanisation in China. After already experiencing the largest human migration in history, what are the public health consequences of this mass movement from rural towns to cities?
Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today announced it plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration by the end of 2014 for the approval of eteplirsen for the treatment of Duchenne muscular dystrophy (DMD).
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular disease, today announced that it received notification from the NASDAQ Stock Market that the Company has demonstrated compliance with the minimum stockholders' equity requirement for the NASDAQ Global Market
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Christine R Peterson, FNP 802 2nd St Nw Ste 1, Bowman, ND 58623-4469 Ph: (701) 523-5555 | Mrs Christine R Peterson, FNP 802 2nd St Nw, Bowman, ND 58623-4483 Ph: (701) 523-5555 |
News Archive
Revolutions Medical Corporation, producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, announced today that recent mass media reports that CT scans cause cancer could rapidly elevate MRI as the technology of choice for musculoskeletal scans and more.
At the third plenum held earlier this month, the Chinese government announced reforms to further drive urbanisation in China. After already experiencing the largest human migration in history, what are the public health consequences of this mass movement from rural towns to cities?
Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today announced it plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration by the end of 2014 for the approval of eteplirsen for the treatment of Duchenne muscular dystrophy (DMD).
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular disease, today announced that it received notification from the NASDAQ Stock Market that the Company has demonstrated compliance with the minimum stockholders' equity requirement for the NASDAQ Global Market
› Verified 6 days ago
Syeda Sana Bischoff, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 608 Highway 12 W, Bowman, ND 58623 Phone: 701-523-3271 | |
Mrs. Megan Maurya Oase, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 608 Highway 12 W, Bowman, ND 58623 Phone: 701-523-3271 | |
Elizabeth Reiten, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 608 Highway 12 W, Bowman, ND 58623 Phone: 701-523-3271 Fax: 701-523-5593 |